Most Instagram posts incorporating a common, asthma-related hashtag promoted products or services that were not supported by the Global Initiative for Asthma (GINA) recommendations.
Patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19.
Although the mortality of patients with high-risk pulmonary embolism has decreased over time, the decrease cannot be attributed to improved treatments for pulmonary embolism.
Anaphylaxis following administration of the Pfizer-BioNTech COVID-19 vaccine occurred at a rate of 11.1 per 1 million doses.
Adult patients with pulmonary arterial hypertension (PAH) who were also obese had worse disease-specific health-related quality of life compared to patients of normal weight.
The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype.
People with asthma were not overrepresented in patients with severe pneumonia because of SARS-CoV-2 infection who required hospitalization.
Patients with obstructive or central sleep apnea experienced improvements in apnea-hypopnea index following treatment with acetazolamide.
The Canadian Thoracic Society’s Position Statement on the Optimization of Asthma Management during the COVID-19 pandemic had several key insights.
Sensitization to environmental fungi was associated with poorer outcomes in patients with COPD.
